These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 9399151)

  • 1. Variability analysis of HIV-1 gp120 V3 region: II. Hierarchy of taxons.
    Shchelkanov MYu ; Yudin AN; Antonov AV; Soinov LA; Zalunin VV; Vedenov AA; Karamov EV
    J Biomol Struct Dyn; 1997 Oct; 15(2):231-41. PubMed ID: 9399151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability analysis of HIV-1 gp120 V3 region: I. Point estimators for the amino acid distribution characteristics.
    Shchelkanov MYu ; Yudin AN; Antonov AV; Starikov NS; Vedenov AA; Karamov EV
    J Biomol Struct Dyn; 1997 Oct; 15(2):217-29. PubMed ID: 9399150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability analysis of HIV-1 gp120 V3 region: III. Distinctions between various sets of peptide fragments derived from the sequences belonging to different HIV-1 taxons.
    Shchelkanov MYu ; Starikov NS; Yaroslavtsev IV; Yudin AN; Antonov AV; Novak IL; Vedenov AA; Karamov EV
    J Biomol Struct Dyn; 1997 Dec; 15(3):537-46. PubMed ID: 9440000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dependencies of substitution steps number on Hamming distance are identical for one-parameter discrete models of both direct and parallel genetic diversity.
    Shchelkanov MY; Soinov LA; Zalunin VV; Starikov NS; Natan AA; Kireev VB; Karamov EV
    J Biomol Struct Dyn; 1998 Aug; 16(1):133-8. PubMed ID: 9745902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability analysis of HIV-1 gp120 V3 region: IV. Distribution functions for intra- and inter-subtype amino acid hamming distances.
    Shchelkanov MYu ; Starikov NS; Yaroslavtsev IV; Tsvetkov PO; Yudin AN; Denisov MV; Slavsky AA; Vedenov AA; Karamov EV
    J Biomol Struct Dyn; 1998 Apr; 15(5):877-85. PubMed ID: 9619510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in HIV type 1 V3 region env sequences from Mozambique.
    Engelbrecht S; Koulinska I; Smith TL; Barreto J; van Rensburg EJ
    AIDS Res Hum Retroviruses; 1998 Jun; 14(9):803-5. PubMed ID: 9643380
    [No Abstract]   [Full Text] [Related]  

  • 7. Human immunodeficiency virus type 1 subtypes among Malaysian intravenous drug users.
    Saraswathy TS; Ng KP; Sinniah M
    Southeast Asian J Trop Med Public Health; 2000 Jun; 31(2):283-6. PubMed ID: 11127327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
    J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV type 1 subtypes in Argentina and genetic heterogeneity of the V3 region.
    Campodonico M; Janssens W; Heyndrickx L; Fransen K; Leonaers A; Fay FF; Taborda M; Van der Groen G; Fay OH
    AIDS Res Hum Retroviruses; 1996 Jan; 12(1):79-81. PubMed ID: 8825623
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular epidemiology of HIV-1 in the former Soviet Union: analysis of env V3 sequences and their correlation with epidemiologic data.
    Bobkov A; Garaev MM; Rzhaninova A; Kaleebu P; Pitman R; Weber JN; Cheingsong-Popov R
    AIDS; 1994 May; 8(5):619-24. PubMed ID: 8060542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular analysis of the principal neutralization epitope (V3 loop) of human immunodeficiency virus type 1 in Argentina].
    Gómez Carrillo M; Piccardo C; Libonatti O
    Rev Argent Microbiol; 1992; 24(2):91-101. PubMed ID: 1298019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A functional model of the central epitope of the V3 loop of HIV-1 gp120 when complexed with antibodies].
    Shchelkanov MIu; Iaroslavtseva NG; Emel'ianov AV; Sakhuriia IB; Abélian AV; Verevochkin SV; Kozlov AP; Karamov EV
    Mol Biol (Mosk); 1998; 32(6):1062-74. PubMed ID: 9929887
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biological characteristics of HIV-1 isolates circulating in China are linked to its env V3 loop sequence variability].
    Hei FX; Hong KX; Song YH; Tang HL; Peng H; Xu JQ; Xing H; Shao YM
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1968-72. PubMed ID: 15730807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphism of envelope V3 region of HIV type 1 subtypes A, C, and D from Nairobi, Kenya.
    Zachar V; Goustin AS; Zacharova V; Hager H; Koppelhus U; Womble DD; Liu X; Bambra C; Nyongo A; Ebbesen P
    AIDS Res Hum Retroviruses; 1996 Jan; 12(1):75-8. PubMed ID: 8825622
    [No Abstract]   [Full Text] [Related]  

  • 15. Simultaneous introduction of distinct HIV-1 subtypes into different risk groups in Russia, Byelorussia and Lithuania.
    Lukashov VV; Cornelissen MT; Goudsmit J; Papuashvilli MN; Rytik PG; Khaitov RM; Karamov EV; de Wolf F
    AIDS; 1995 May; 9(5):435-9. PubMed ID: 7639968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usage.
    Svicher V; Alteri C; Artese A; Zhang JM; Costa G; Mercurio F; D'Arrigo R; Alcaro S; Palù G; Clementi M; Zazzi M; Andreoni M; Antinori A; Lazzarin A; Ceccherini-Silberstein F; Perno CF;
    Antivir Ther; 2011; 16(7):1035-45. PubMed ID: 22024519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic characteristics of the V3 region associated with CXCR4 usage in HIV-1 subtype C isolates.
    Coetzer M; Cilliers T; Ping LH; Swanstrom R; Morris L
    Virology; 2006 Dec 5-20; 356(1-2):95-105. PubMed ID: 16942785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of the variation of 32 HIV-1 V3 loop from infected Chinese blood/plasma donors].
    Dai L; Lu JF; Huang XJ; Shi Y; Chen DX; Wu H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Feb; 22(1):27-9. PubMed ID: 18414693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational preferences of a chimeric peptide HIV-1 immunogen from the C4-V3 domains of gp120 envelope protein of HIV-1 CAN0A based on solution NMR: comparison to a related immunogenic peptide from HIV-1 RF.
    Vu HM; de Lorimier R; Moody MA; Haynes BF; Spicer LD
    Biochemistry; 1996 Apr; 35(16):5158-65. PubMed ID: 8611499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell type-specific heterogeneity of the HIV-1 V3 loop in infected individuals: selection of virus in macrophages and plasma.
    Yamashita A; Yamamoto N; Matsuda J; Koyanagi Y
    Virology; 1994 Oct; 204(1):170-9. PubMed ID: 7916512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.